Understanding Immunotherapy and Colorectal Cancer
Immunotherapy, also called immunology or immuno-oncology, uses the body's own immune system to fight off cancer and the spread of tumors. Immunotherapy is showing a lot of promise. Biomarker testing c...
Author: FightCRC
Added: 08/09/2016 (Source: Oncology Tube)
Source: Oncology Tube - August 9, 2016 Category: Cancer & Oncology Source Type: podcasts
ASCO: GI-Colorectal Cancer Abstracts
Jason A. Zell, DO, MPH<br />Associate Professor, Depts. Of Medicine & Epidemiology<br />School of Medicine<br />University of California, Irvine discusses newly released data from ASCO 2016 concerning the GI-Col...
Author: moasc
Added: 07/18/2016 (Source: Oncology Tube)
Source: Oncology Tube - July 18, 2016 Category: Cancer & Oncology Source Type: podcasts
A protein-based CVD risk score, trends in diet among US adults, herbal therapies for menopause, USPSTF colon cancer screening recommendations, and more
Editor's Audio Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the June 21, 2016 issue (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - June 21, 2016 Category: Journals (General) Authors: JAMA, the Journal of the American Medical Association, and The JAMA Network Source Type: podcasts
USPSTF Recommendation Statement: Screening for Colorectal Cancer
Interview with Douglas K. Owens, MD, MS, author of Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - June 15, 2016 Category: Journals (General) Authors: JAMA, the Journal of the American Medical Association, and The JAMA Network Source Type: podcasts
Screening for Colorectal Cancer
Interview with Douglas K. Owens, MD, MS, author of Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - June 15, 2016 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
Emerging Treatment Options for mCRC Patients in the Late-line Setting
Metastatic Colorectal Cancer" symposium, Eric Van Cutsem discusses the emerging treatment options for metastatic colorectal cancer patients in the late-line setting.
A continuing education program ...
Author: imedex
Added: 05/22/2016 (Source: Oncology Tube)
Source: Oncology Tube - May 23, 2016 Category: Cancer & Oncology Source Type: podcasts
Management of Adverse Events Associated with Third-line Treatments for mCRC
In this presentation from the "Individualizing Late-Line Treatment for Patients with Metastatic Colorectal Cancer" symposium, Dr. Howard S. Hochster discusses the management of adverse events associat...
Author: imedex
Added: 05/22/2016 (Source: Oncology Tube)
Source: Oncology Tube - May 23, 2016 Category: Cancer & Oncology Source Type: podcasts
Expert Perspectives: Optimizing Late-Line Therapy for Patients with Metastatic Colorectal Cancer
This discussion presents a discussion between world-renowned thought leaders Axel Grothey, Howard Hochster, and Eric Van Cutsem, who elucidate the effective implementation of new late-line CRC treatme...
Author: imedex
Added: 05/22/2016 (Source: Oncology Tube)
Source: Oncology Tube - May 23, 2016 Category: Cancer & Oncology Source Type: podcasts
Risk-benefit ratio for TAS-102 in advanced treatment refractory colorectal cancer ASCO GI 2016
Eric Van Cutsem, MD of University of Leuven discusses the risk-benefit ratio for TAS-102 in advanced treatment refractory colorectal cancer at ASCO GI 2016
Author: ASCOGI2016
Added: 01/29/2016 (Source: Oncology Tube)
Source: Oncology Tube - January 29, 2016 Category: Cancer & Oncology Source Type: podcasts
Therapeutic algorithm for TAS-102 in metastatic colorectal cancer ASCO GI 2016
Eric Van Cutsem, MD of University of Leuven discusses the therapeutic algorithm for TAS-102 in metastatic colorectal cancer at ASCO GI 2016
Author: ASCOGI2016
Added: 01/29/2016 (Source: Oncology Tube)
Source: Oncology Tube - January 29, 2016 Category: Cancer & Oncology Source Type: podcasts
Biggest questions facing the treatment of colorectal cancer ASCO GI 2016
Axel Grothey, MD of Mayo Clinic discusses the biggest questions facing the treatment of colorectal cancer at ASCO GI 2016
Author: ASCOGI2016
Added: 01/29/2016 (Source: Oncology Tube)
Source: Oncology Tube - January 29, 2016 Category: Cancer & Oncology Source Type: podcasts
How has the last 10 years changed the way you treat metastatic colorectal cancer ASCO GI 2016
Axel Grothey, MD of Mayo Clinic discusses how has the last 10 years changed the way you treat metastatic colorectal cancer
Author: ASCOGI2016
Added: 01/29/2016 (Source: Oncology Tube)
Source: Oncology Tube - January 29, 2016 Category: Cancer & Oncology Source Type: podcasts
Immunotherapy, MET, and HER 2+ research is the future of colorectal cancer treatment ASCO GI 2016
Axel Grothey, MD of Mayo Clinic discusses immunotherapy, MET, and HER 2+ research is the future of colorectal cancer treatment ASCO GI 2016
Author: ASCOGI2016
Added: 01/29/2016 (Source: Oncology Tube)
Source: Oncology Tube - January 29, 2016 Category: Cancer & Oncology Source Type: podcasts
Key trials that will move treatment forward in colorectal cancer ASCO GI 2016
Axel Grothey, MD of Mayo Clinic discusses key trials that will move treatment forward in colorectal cancer at ASCO GI 2016
Author: ASCOGI2016
Added: 01/29/2016 (Source: Oncology Tube)
Source: Oncology Tube - January 29, 2016 Category: Cancer & Oncology Source Type: podcasts
More money should be allocated to early detection and screening in colorectal cancer ASCO GI 2016
Axel Grothey, MD of Mayo Clinic discusses why more money should be allocated to early detection and screening in colorectal cancer at ASCO GI 2016
Author: ASCOGI2016
Added: 01/29/2016 (Source: Oncology Tube)
Source: Oncology Tube - January 29, 2016 Category: Cancer & Oncology Source Type: podcasts
